| Apr 9 2024 |
California Greatly Expands List of Cosmetics Fragrances Reportable as Allergens |
ArentFox Schiff LLP |
| Apr 9 2024 |
The Italian DPA Has Its Eyes on Biometric IDs – Another Fight on Tech or a Win for Privacy? |
Squire Patton Boggs (US) LLP |
| Apr 8 2024 |
FDA Publishes Draft Guidance on NDIN Master Files |
Keller and Heckman LLP |
| Apr 8 2024 |
Will Hemp Save the World, Before the Government Kills It? |
Bradley Arant Boult Cummings LLP |
| Apr 8 2024 |
While You Were Sleeping – Development of the Hydrogen Hubs Keeps On Rolling |
Barnes & Thornburg LLP |
| Apr 6 2024 |
EPA Proposes to Require Submission of Health and Safety Studies for 16 Chemicals Being Considered for TSCA Risk Evaluation |
Bergeson & Campbell, P.C. |
| Apr 5 2024 |
Pharmaceutical Companies May Be the First Targets of the Washington State My Health My Data Act |
Greenberg Traurig, LLP |
| Apr 5 2024 |
New York Cannabis Regulations Are (Initially Ruled) Unconstitutional, Says New York Judge |
ArentFox Schiff LLP |
| Apr 4 2024 |
Proposal to Revamp Alabama Medical Cannabis Program Met with Near-Unanimous Opposition |
Bradley Arant Boult Cummings LLP |
| Apr 4 2024 |
Cancer Drugs (Antibody Drug Conjugates): An FDA Perspective |
Foley & Lardner LLP |
| Apr 4 2024 |
FDA Reminds Stakeholders of Animal Drug ‘Approved by FDA’ Labeling Requirements |
Greenberg Traurig, LLP |
| Apr 4 2024 |
Take the Beer Goggles Off: Ambiguity Prevents Summary Judgment |
McDermott Will & Schulte LLP |
| Apr 4 2024 |
CTP Releases New 5-year Strategic Plan |
Keller and Heckman LLP |
| Apr 4 2024 |
AMS Requests Information to Update List of Bioengineered Foods |
Bergeson & Campbell, P.C. |
| Apr 3 2024 |
FTC’s Campaign Against Improper Orange Book Listings Continues with Amicus Brief in Teva’s Challenge of Amneal Asthma Inhaler ANDA |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 3 2024 |
EPA Describes Future of Its Nanotechnology Research |
Bergeson & Campbell, P.C. |
| Apr 3 2024 |
FDA Warning Letter Is a Stark Reminder that if You Claim Your Product Is RUO, it Has to Be RUO |
Mintz |
| Apr 3 2024 |
US FDA to Develop Regulatory Scheme for AI in Medical Products, Foster International Cooperation |
Greenberg Traurig, LLP |
| Apr 3 2024 |
The “Fix” Is In: Alabama Legislature to Consider Controversial Proposal to Revamp Stalled Medical Cannabis Program |
Bradley Arant Boult Cummings LLP |
| Apr 3 2024 |
FDA Revokes Standard of Identity for Frozen Cherry Pie |
Keller and Heckman LLP |
| Apr 3 2024 |
This Week in 340B: March 19 – 25, 2024 |
McDermott Will & Schulte LLP |
| Apr 3 2024 |
This Week in 340B: March 13 – 18, 2024 |
McDermott Will & Schulte LLP |
| Apr 3 2024 |
New Florida Third-Party Food Delivery Law in Effect |
Greenberg Traurig, LLP |
| Apr 3 2024 |
This Week in 340B: March 26 – April 1, 2024 |
McDermott Will & Schulte LLP |
| Apr 2 2024 |
NIOSH Science Blog Item Highlights 20 Years of NTRC’s Field Studies Team |
Bergeson & Campbell, P.C. |
| Apr 2 2024 |
Litigation Minute: Class-Action Challenges to Natural and Clean Beauty Product Claims |
K&L Gates LLP |
| Apr 2 2024 |
Unpacking Averages: Adverse Events for Device-Lead Combination Products |
Epstein Becker & Green, P.C. |
| Apr 2 2024 |
FSIS Updates Guidelines for Label Approval |
Keller and Heckman LLP |
| Apr 2 2024 |
Soaring High on Hoverbikes: Look Ma, No Ground! |
Nishith Desai Associates |
| Apr 1 2024 |
FDA: New Guidance for Non-interventional Studies of Drug Safety and Effectiveness |
Foley & Lardner LLP |
| Apr 1 2024 |
Weed at Work: Can Georgia Employers Still Drug Test? |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 1 2024 |
Recent Delaware Coverage Decisions on Relatedness Leaves D&O Claim Uncertainties |
Hunton Andrews Kurth |
| Apr 1 2024 |
So, You’ve Been Sued in a Labeling Class Action. Now What? |
McDermott Will & Schulte LLP |
| Apr 1 2024 |
FDCA Preemption: A Powerful Tool for Defending Class Actions |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 1 2024 |
APHIS Seeks Comment on Draft EIS for Deregulation of Maize Developed Using Genetic Engineering |
Bergeson & Campbell, P.C. |
